Delivery Order SPE2DB24D2109-SPE2DB24FHWAN
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $12,548 delivery order contract to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 pharmaceutical syringes. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a firm...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of GARDASIL 9 SYRINGE 0.5ML. The $4,705.50 firm fixed-price contract has a completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $9,366.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $3,087.58 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565322699 GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The contract has a ceiling value of $8,737.35 and an ultimate completion date of February 28, 2025. This contract is not designated as a set-aside. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of GARDASIL 9 syringes. This $37,681.42 Firm Fixed Price contract has a completion date of December 10, 2024. The award is not associated with a set-aside program. AmerisourceBergen, the prime contractor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $9,761.55 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,684,229 units of GARDASIL 9 vaccine syringes (0.5 mL) with a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025,...
The Defense Logistics Agency (DLA) awarded a $3,517.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4565744306 GARDASIL 9 SYRINGE 0.5ML. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside...
This is a $15,074.32 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringe 0.5ML. The contract has a firm fixed price pricing structure and an ultimate completion date of August 13, 2024. This contract is not set aside for any specific socioeconomic program. The contract is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government agency Medical Supply Chain, a component of the Department of Defense, awarded a $7,031.88 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide GARDASIL 9 SYRINGE 0.5ML. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The DLA IDC allows the agency to...